These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19640240)

  • 1. Simple dosage inaccuracy might be the cause of serious side effects of topiramate.
    Meral C; Aydinoz S
    Clin Toxicol (Phila); 2009 Aug; 47(7):691. PubMed ID: 19640240
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment retention with topiramate.
    Deckers CL; Renier WO
    Epilepsia; 2001 Feb; 42(2):290-1. PubMed ID: 11240609
    [No Abstract]   [Full Text] [Related]  

  • 3. Topiramate in the treatment of severe myoclonic epilepsy in infancy.
    Nieto-Barrera M; Candau R; Nieto-Jimenez M; Correa A; del Portal LR
    Seizure; 2000 Dec; 9(8):590-4. PubMed ID: 11162758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low sweat secretion due to topiramate].
    Sánchez Calso A; Antón Sanz MC
    Aten Primaria; 2002 Sep; 30(4):257-8. PubMed ID: 12237033
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitigating cognitive side effects associated with topiramate.
    Antai-Otong D
    Perspect Psychiatr Care; 2005; 41(2):92-3. PubMed ID: 15924583
    [No Abstract]   [Full Text] [Related]  

  • 6. Topiramate and fulminant liver failure.
    Bjøro K; Gjerstad L; Bentdal O; Osnes S; Schrumpf E
    Lancet; 1998 Oct; 352(9134):1119. PubMed ID: 9798593
    [No Abstract]   [Full Text] [Related]  

  • 7. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
    Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
    Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate-induced myoclonus and psychosis during migraine prophylaxis.
    Miller AD; Prost VM; Bookstaver PB; Gaines KJ
    Am J Health Syst Pharm; 2010 Jul; 67(14):1178-80. PubMed ID: 20592323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia.
    Ziad el K; Rahi AC; Hamdan SA; Mikati MA
    Neurology; 2005 Oct; 65(7):1139-40. PubMed ID: 16217081
    [No Abstract]   [Full Text] [Related]  

  • 10. [Compared clinical study on treatment of childhood epilepsy with different escalating dosage protocol of topiramate].
    Huang SP; He GZ; Chen ZQ; He J
    Zhonghua Er Ke Za Zhi; 2003 Mar; 41(3):230-2. PubMed ID: 14756968
    [No Abstract]   [Full Text] [Related]  

  • 11. Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder.
    Andrade C
    Bipolar Disord; 2001 Aug; 3(4):211-2. PubMed ID: 11552960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Probable Topiramate-Induced Limbs Paraesthesia and Rigid Fingers Flexion.
    Pratico AD; Ruggieri M; Falsaperla R; Pavone P
    Curr Drug Saf; 2018; 13(2):131-136. PubMed ID: 29437013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of type IV hypersensitivity to topiramate and carbamazepine.
    Schiavino D; Nucera E; Buonomo A; Musumeci S; Pollastrini E; Roncallo C; Lombardo C; Alonzi C; Pecora V; Corradini C; De Pasquale T; Patriarca G
    Contact Dermatitis; 2005 Mar; 52(3):161-2. PubMed ID: 15811034
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of trigeminal neuralgia with low doses of topiramate.
    Domingues RB; Kuster GW; Aquino CC
    Arq Neuropsiquiatr; 2007 Sep; 65(3B):792-4. PubMed ID: 17952282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration.
    Oulis P; Potagas C; Masdrakis VG; Thomopoulos Y; Kouzoupis AV; Soldatos CR
    Clin Neuropharmacol; 2008; 31(6):366-7. PubMed ID: 19050415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate and hepatotoxicity.
    Doan RJ; Clendenning M
    Can J Psychiatry; 2000 Dec; 45(10):937-8. PubMed ID: 11190367
    [No Abstract]   [Full Text] [Related]  

  • 20. Topiramate-induced psychosis.
    Kober D; Gabbard GO
    Am J Psychiatry; 2005 Aug; 162(8):1542. PubMed ID: 16055782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.